PreprintAll rights reservedmedRxiv
Tripelennamine 1% topical cream versus diphenhydramine 1% topical cream for the relief of histamine-induced itching: A proof-of-concept study in healthy adults.
- 1Palm Beach Atlantic University
Related
- Topical herbal medicine as treatment for chemotherapy-induced peripheral neuropathy: a systematic review of randomized controlled trials
- Development and Optimization of a Lupeol-Loaded Bilosomal Gel for Enhanced Topical Therapy of Imiquimod-Induced Psoriasis.
- Iatrogenic Cushing Syndrome With Glucocorticoid-Induced Adrenal Insufficiency Following Prolonged Topical Clobetasol Use in an Adolescent
- Anticholinergic Co-Medication Burden Does Not Predict Cardiac Toxicity in Adolescent Diphenhydramine Exposure: A Pharmacovigilance Study of the FDA Adverse Event Monitoring System
- Topical Delgocitinib for Capecitabine-Induced Hand–Foot Syndrome: A Therapeutic Option?
BibTeX
@misc{nornoo2026tripelennamine,
title = {{Tripelennamine 1% topical cream versus diphenhydramine 1% topical cream for the relief of histamine-induced itching: A proof-of-concept study in healthy adults.}},
author = {A. O. Nornoo and H. Maarsingh},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.01.26361939},
url = {https://www.medrxiv.org/content/10.64898/2026.09.01.26361939v1},
}
RIS
TY - UNPB
TI - Tripelennamine 1% topical cream versus diphenhydramine 1% topical cream for the relief of histamine-induced itching: A proof-of-concept study in healthy adults.
AU - A. O. Nornoo
AU - H. Maarsingh
PY - 2026
DA - 2026/09/01
PB - medRxiv
DO - 10.64898/2026.09.01.26361939
UR - https://www.medrxiv.org/content/10.64898/2026.09.01.26361939v1
ER -